Torsades de pointes following cardioversion: case history and literature review
- PMID: 14692159
- DOI: 10.1016/s1036-7314(05)80037-2
Torsades de pointes following cardioversion: case history and literature review
Abstract
Torsades de pointes (TDP) is a relatively uncommon but potentially fatal cardiac arrhythmia which occurs in patients with long QT syndromes (LQTS). This literature review and case history investigate the causes, symptoms, presentation and treatment of torsades, focusing on drug induced torsades developing after successful cardioversion. In torsades, imbalanced positive ion flows result in early after-depolarisations (EADs) and increased variability in repolarisation rates. These combine to create an unstable re-entrant polymorphic ventricular tachycardia (VT) which can cause patients to suffer symptoms progressing from syncope to ventricular fibrillation (VF) arrest. Typically, torsades has a twisting morphological presentation on rhythm strips due to the irregularity of its re-entry pattern. The arrhythmia is more common in women. Intravenous magnesium is the initial emergency treatment in torsades. The case history illustrates the progressive acquisition of risk factors for drug induced torsades in a patient treated with sotalol following cardioversion. Typical progressive rhythm strip, electrocardiograph (ECG), and QT & corrected QT interval (QTc) interval changes occurring with the arrhythmia are presented.
Similar articles
-
Efficacy and proarrhythmia with the use of d,l-sotalol for sustained ventricular tachyarrhythmias.J Cardiovasc Pharmacol. 1997 Mar;29(3):373-81. doi: 10.1097/00005344-199703000-00011. J Cardiovasc Pharmacol. 1997. PMID: 9125676
-
A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).J Pharmacol Toxicol Methods. 2013 Sep-Oct;68(2):250-259. doi: 10.1016/j.vascn.2013.01.003. Epub 2013 Jan 19. J Pharmacol Toxicol Methods. 2013. PMID: 23337247
-
Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study.Arch Cardiovasc Dis. 2019 Nov;112(11):699-712. doi: 10.1016/j.acvd.2019.06.008. Epub 2019 Aug 30. Arch Cardiovasc Dis. 2019. PMID: 31477476
-
[Torsade de pointes and QT syndrome].Med Klin (Munich). 1995 Apr 15;90(4):240-5. Med Klin (Munich). 1995. PMID: 7776938 Review. German. No abstract available.
-
Hands-on help Torsades de pointes.RN. 2004 Oct;67(10):24ac1-4. RN. 2004. PMID: 15552376 Review.
Cited by
-
QTc Dynamics Following Cardioversion for Persistent Atrial Fibrillation.Front Cardiovasc Med. 2022 Jun 3;9:881446. doi: 10.3389/fcvm.2022.881446. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35722129 Free PMC article.
-
Efficacy of class III antiarrhythmics and magnesium combination therapy for atrial fibrillation.Pharm Pract (Granada). 2012 Apr;10(2):65-71. doi: 10.4321/s1886-36552012000200001. Epub 2012 Jun 30. Pharm Pract (Granada). 2012. PMID: 24155819 Free PMC article. Review.
-
Survival after prolonged resuscitation with 99 defibrillations due to Torsade De Pointes cardiac electrical storm: a case report.Scand J Trauma Resusc Emerg Med. 2010 Feb 6;18:7. doi: 10.1186/1757-7241-18-7. Scand J Trauma Resusc Emerg Med. 2010. PMID: 20137096 Free PMC article.